Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2.
作者信息
Baser M E, Wallace A J, Strachan T, Evans D G
出版信息
J Med Genet. 2000 Jul;37(7):542-3. doi: 10.1136/jmg.37.7.542.
Abstract
摘要
相似文献
1
Clinical and molecular correlates of somatic mosaicism in neurofibromatosis 2.神经纤维瘤病2型体细胞镶嵌现象的临床及分子关联
J Med Genet. 2000 Jul;37(7):542-3. doi: 10.1136/jmg.37.7.542.
2
An update on age related mosaic and offspring risk in neurofibromatosis 2 (NF2).神经纤维瘤病2型（NF2）中与年龄相关的嵌合体及子代风险的最新进展。
J Med Genet. 2009 Nov;46(11):792. doi: 10.1136/jmg.2009.070342.
3
Multifocality in neurofibromatosis type 2.2型神经纤维瘤病中的多灶性。
Neuro Oncol. 2015 Apr;17(4):481-2. doi: 10.1093/neuonc/nou338. Epub 2014 Dec 23.
4
Somatic mosaicism in neurofibromatosis 2: prevalence and risk of disease transmission to offspring.神经纤维瘤病2型中的体细胞嵌合现象：患病率及疾病遗传给后代的风险。
J Med Genet. 2003 Jun;40(6):459-63. doi: 10.1136/jmg.40.6.459.
5
[Selected problems of neurofibromatosis with presentation of a case of multiple intracranial and intramedullary tumors].[神经纤维瘤病的一些选定问题及一例多发颅内和髓内肿瘤病例报告]
Neurol Neurochir Pol. 1998 Nov-Dec;32(6):1563-9.
6
Unilateral vestibular schwannoma and meningiomas in a patient with PIK3CA-related segmental overgrowth: Co-occurrence of mosaicism for 2 rare disorders.患者同时患有单侧听神经鞘瘤和脑膜瘤，存在 PIK3CA 相关节段性过度生长：2 种罕见疾病的镶嵌性共存。
Clin Genet. 2018 Jan;93(1):187-190. doi: 10.1111/cge.13099. Epub 2017 Nov 29.
7
Middle ear schwannoma extending from the cerebellopontine angle in a patient with neurofibromatosis type 2.2型神经纤维瘤病患者中，起源于小脑脑桥角的中耳神经鞘瘤。
Otolaryngol Head Neck Surg. 2007 Sep;137(3):511-2. doi: 10.1016/j.otohns.2007.04.008.
8
Vestibular schwannoma growth.前庭神经鞘瘤生长
J Neurosurg. 2004 Apr;100(4):734-5; author reply 735. doi: 10.3171/jns.2004.100.4.0734.
9
[Acustic neurinoma: correlation between clinic and MRI].[听神经瘤：临床与磁共振成像的相关性]
Recenti Prog Med. 2013 Jul-Aug;104(7-8):299-302. doi: 10.1701/1315.14564.
10
Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2.2型神经纤维瘤病患者前庭神经鞘瘤生长的预测因素。
J Neurosurg. 2002 Feb;96(2):217-22. doi: 10.3171/jns.2002.96.2.0217.
引用本文的文献
1
The genetic landscape and possible therapeutics of neurofibromatosis type 2.2型神经纤维瘤病的遗传图谱及可能的治疗方法。
Cancer Cell Int. 2023 May 23;23(1):99. doi: 10.1186/s12935-023-02940-8.
2
Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2.神经纤维瘤病 2 型中的基因组学、表观遗传学和听力损失。
Otol Neurotol. 2020 Jun;41(5):e529-e537. doi: 10.1097/MAO.0000000000002613.
Zotero 插件